ライフサイエンスコーパス: chorioallantoic

1 pha or RANTES, were highly angiogenic in the chorioallantoic assay, suggesting a possible pathogenic

2 mental processes of yolk sac vasculogenesis, chorioallantoic attachment, and embryonic axis elongatio

3 The mutant mice have gross defects in chorioallantoic branching morphogenesis and placental va

4 significantly increased angiogenesis in the chorioallantoic (CAM) assay in ovo.

5 e, while its absence in mice leads to failed chorioallantoic fusion and death at embryonic day 10.5 (

6 mozygous for the null allele fail to undergo chorioallantoic fusion and die by 10.5 days post coitus.

7 We showed that murine FGFR2 is essential for chorioallantoic fusion and placenta trophoblast cell pro

8 one third of the mutants failed to form the chorioallantoic fusion junction and the remaining mutant

9 ly returned to the tip, often colonizing the chorioallantoic fusion junction.

10 Failure of chorioallantoic fusion occurred in about two-thirds of c

11 olin, ZFP36L1, and ZFP36L2, in inflammation, chorioallantoic fusion, and early embryonic development,

12 approximately 30% succumbed to a failure in chorioallantoic fusion, and the reminder perished due to

13 The alpha4 integrin protein, required for chorioallantoic fusion, is not expressed by cells in the

14 pithelium, caudal dysgenesis, and failure of chorioallantoic fusion.

15 lantois, consistent with a potential role in chorioallantoic fusion.

16 and about 50% of them do not undergo normal chorioallantoic fusion.

17 ve beyond mid-gestation was due to defective chorioallantoic fusion.

18 ural tube defects, and die due to failure of chorioallantoic fusion.

19 to form yolk sac vasculature, and 35% failed chorioallantoic fusion.

20 ionic trophoblast (BCT) cells located at the chorioallantoic interface in murine placentas.

21 arity and basement membrane integrity at the chorioallantoic interface, as well as a severe disruptio

22 furcation (nonsprouting angiogenesis) at the chorioallantoic junction, leading to an undervasculariza

23 sing recombinant fragments of the protein on chorioallantoic membrane (CAM) angiogenesis and endothel

24 released from a polymeric implant in a chick chorioallantoic membrane (CAM) assay and laser-induced e

25 We used the chick embryo chorioallantoic membrane (CAM) assay to test the hypothe

26 In the chick chorioallantoic membrane (CAM) assay used to measure ang

27 An in vivo chorioallantoic membrane (CAM) assay was performed using

28 ls (HUVEC) differentiation assay and chicken chorioallantoic membrane (CAM) assay we document that st

29 is: the endothelial cell culture system, the chorioallantoic membrane (CAM) assay, and the laser-indu

30 epG2 tumor growth in a modified chick embryo chorioallantoic membrane (CAM) assay, associated with a

31 In the chick chorioallantoic membrane (CAM) assay, SsnB caused signif

32 ocomputed tomography; MicroCT) and using the chorioallantoic membrane (CAM) assay, we present and val

33 asis in both in vivo mouse models and in the chorioallantoic membrane (CAM) assay.

34 icant antitumor activity and low toxicity in chorioallantoic membrane (CAM) assay.

35 stimulated developmental angiogenesis in the chorioallantoic membrane (CAM) assay.

36 neovascularization in the chick embryo chick chorioallantoic membrane (CAM) assay.

37 says using human vascular endothelial cells, chorioallantoic membrane (CAM) assays and xenograft tumo

38 Chorioallantoic membrane (CAM) assays utilizing Japanese

39 tro and to stimulate angiogenesis ex vivo in chorioallantoic membrane (CAM) assays.

40 tested the hypothesis that the chick embryo chorioallantoic membrane (CAM) can be used as a bioreact

41 scaffold and incubated on the chicken embryo chorioallantoic membrane (CAM) for 7 days.

42 collagen onplants placed on the chick embryo chorioallantoic membrane (CAM) has been used in this stu

43 In a Chick Chorioallantoic Membrane (CAM) in vivo model, lincNMR-de

44 We used the chicken chorioallantoic membrane (CAM) model to determine whethe

45 ly expressed in MNA(+) NB and, using a chick chorioallantoic membrane (CAM) model, as a crucial regul

46 Using a chicken chorioallantoic membrane (CAM) model, we demonstrated th

47 own for (SiFA)SeFe-rhTATE2 using the chicken chorioallantoic membrane (CAM) model.

48 C ES-2 cell tumor growth and metastasis in a chorioallantoic membrane (CAM) model.

49 to deliver a therapeutic agent by using the chorioallantoic membrane (CAM) model.

50 lied topically on embryonic day (E) 7 to the chorioallantoic membrane (CAM) of quail embryos cultured

51 nic growth factors in onplants placed on the chorioallantoic membrane (CAM) of the chick embryos is c

52 nal, Myr-P3k, can induce angiogenesis in the chorioallantoic membrane (CAM) of the chicken embryo.

53 MD on the production of blood vessels in the chorioallantoic membrane (CAM) of the developing chicken

54 tracers, but the growth of tumors on chicken chorioallantoic membrane (CAM) provides a more rapid, lo

55 also used in vivo tumor growth on the chick chorioallantoic membrane (CAM) to observe the disseminat

56 s (HUVECs) and neovascularization in chicken chorioallantoic membrane (CAM) was examined by MTT assay

57 d in developing blood vessels of the chicken chorioallantoic membrane (CAM), a highly vascular embryo

58 injected intravenously into the chick embryo chorioallantoic membrane (CAM), and mRNA levels in the m

59 fibroblast growth factor (bFGF) on the chick chorioallantoic membrane (CAM), endothelial cell mitogen

60 eveloped using human trabecular bone and the chorioallantoic membrane (CAM), to form a functioning va

61 and stimulated vascular growth in the chick chorioallantoic membrane (CAM).

62 vement of Na+ in either direction across the chorioallantoic membrane according to the changing deman

63 orphogenesis, and blood vessel growth in the chorioallantoic membrane and in Matrigel plug assays.

64 ood vessels in vivo as assessed by the chick chorioallantoic membrane and Matrigel plug assays.

65 elial growth factor (VEGF) function in chick chorioallantoic membrane and matrigel plug assays.

66 ntagonists inhibit angiogenesis in the chick chorioallantoic membrane and neovascularization of mouse

67 n, microtubule formation and angiogenesis in chorioallantoic membrane and nude mice models.

68 peptide were demonstrated by using the chick chorioallantoic membrane and rat corneal micropocket ass

69 ood vessels in vivo as assessed by the chick chorioallantoic membrane and the matrigel plug assays.

70 ogenic activity by two in vivo models, chick chorioallantoic membrane and zebrafish embryos.

71 Finally, in the chicken chorioallantoic membrane angiogenesis assay, FGF-BP1 syn

72 is more potent in blocking C16-induced chick chorioallantoic membrane angiogenesis than C16S.

73 icantly impaired retinal neovascularization, chorioallantoic membrane angiogenesis, and xenograft tum

74 endothelial growth factor-dependent chicken chorioallantoic membrane angiogenic assay recapitulated

75 Chorioallantoic membrane application of follistatin (1 m

76 nd high electric field, was first applied to chorioallantoic membrane as a model system and then to r

77 ts on vascularisation was examined using the chorioallantoic membrane assay (CAM) model and compared

78 rring was explored in HDFs, zebrafish, chick chorioallantoic membrane assay (CAM), and a porcine skin

79 GRO-alpha enhanced angiogenesis in the chick chorioallantoic membrane assay 2.2-fold, providing direc

80 bited angiogenesis, as analyzed by a chicken chorioallantoic membrane assay and a human umbilical vei

81 imately 3-fold decrease in tumor growth on a chorioallantoic membrane assay and approximately 2-fold

82 Using chicken chorioallantoic membrane assay and vascular endothelial

83 oblast growth factor FGF2 (97%) in a chicken chorioallantoic membrane assay at 270 nM, and peptide 40

84 inhibit angiogenesis in vivo using the chick chorioallantoic membrane assay by the inhibition of capi

85 tion potential in vivo in the chicken embryo chorioallantoic membrane assay for blood vessel penetrat

86 togenesis, and blood vessel formation in the chorioallantoic membrane assay have been found.

87 so had an angiogenic activity in vivo in the chorioallantoic membrane assay system.

88 Angiogenesis induced by FGF2 in the chick chorioallantoic membrane assay was also inhibited by SCH

89 In the chick chorioallantoic membrane assay, 6AF treatment profoundly

90 nhibited angiogenesis in vivo in the chicken chorioallantoic membrane assay, and in the Lewis lung sy

91 lary formation on Matrigel, and chick embryo chorioallantoic membrane assay, bortezomib induced a dos

92 l AngsFvs elicited angiogenesis in the chick chorioallantoic membrane assay, demonstrating that Ang i

93 binant Del1 was evaluated in an in ovo chick chorioallantoic membrane assay, it was found to have pot

94 sculitis disrupted blood flow in the chicken chorioallantoic membrane assay, suggesting an antiangiog

95 In the in vivo chick chorioallantoic membrane assay, the mouse and the trunca

96 In an in vivo chick chorioallantoic membrane assay, the PAK peptide specific

97 By using the chick chorioallantoic membrane assay, we show that HCV-infecte

98 ected in vivo angiogenesis assay and a chick chorioallantoic membrane assay, we show that Nodal promo

99 Using an ex vivo chick chorioallantoic membrane assay, we show that opticin inh

100 s was observed with GW654652 using the chick chorioallantoic membrane assay, whereas GW654652 produce

101 outing assay and become more invasive in the Chorioallantoic Membrane assay, which assesses cell pene

102 (rat aortic ring assay), and in vivo (chick chorioallantoic membrane assay, zebrafish, murine wild-t

103 of HT C6 was confirmed in vivo in the chick chorioallantoic membrane assay.

104 development of new veins and arteries in the chorioallantoic membrane assay.

105 cytotrophoblast-derived factors in the chick chorioallantoic membrane assay.

106 ophil elastase, inhibits angiogenesis in the chorioallantoic membrane assay.

107 in vitro and neovascularization in the chick chorioallantoic membrane assay.

108 okine, like vMIP-I and vMIP-II, in the chick chorioallantoic membrane assay.

109 ntial both in vitro and in vivo in the chick chorioallantoic membrane assay.

110 al growth factor-induced angiogenesis in the chorioallantoic membrane assay.

111 om aorta rings and angiogenesis in the chick chorioallantoic membrane assay.

112 AM-1 also mediates angiogenesis in the chick chorioallantoic membrane assay.

113 cells and is angiogenic in vivo in the chick chorioallantoic membrane assay.

114 their effects on vessel formation using the chorioallantoic membrane assay.

115 biocompatibility following evaluation on the chorioallantoic membrane assay.

116 and neuroblastoma tumour growth in the chick chorioallantoic membrane assay.

117 dently induced vessel formation in the chick chorioallantoic membrane assay.

118 the mouse Matrigel plug assay and the chick chorioallantoic membrane assay.

119 ive in the low-pH environment of the chicken chorioallantoic membrane assay.

120 vivo angiogenesis as revealed by chicken egg chorioallantoic membrane assay.

121 and the transformed cells are tumorigenic in chorioallantoic membrane assay.

122 as H2O2-dependent as assessed by the chicken chorioallantoic membrane assay.

123 ells induced angiogenesis in "in vivo" chick chorioallantoic membrane assays that could be reversed w

124 V-ERV infected newly formed blood vessels in chorioallantoic membrane assays.

125 iserum in both endothelial proliferation and chorioallantoic membrane assays.

126 giogenin-induced angiogenesis in the chicken chorioallantoic membrane at a dose as low as 20 ng per e

127 vessels, and eventually observed inside the chorioallantoic membrane capillaries, thus reflecting ea

128 The properties of chorioallantoic membrane derived from Large White Landra

129 the central cell-binding domain to the chick chorioallantoic membrane enhanced angiogenesis in an int

130 cular endothelial growth factor in the chick chorioallantoic membrane in vivo.

131 nt fibroblasts explanted atop the live chick chorioallantoic membrane lack tissue-invasive potential

132 avasation of tumor cells in an in vivo chick chorioallantoic membrane model of metastasis as well as

133 Furthermore, in an in ovo chick chorioallantoic membrane model, overexpression of EMILIN

134 r 221*2-mediated angiogenesis in the chicken chorioallantoic membrane model.

135 angiogenesis have been studied in the chick chorioallantoic membrane model.

136 wth factor-induced angiogenesis in the chick chorioallantoic membrane model.

137 inhibits angiogenesis in Matrigel and chick chorioallantoic membrane models and also inhibits metast

138 lpha7-nAChR was confirmed in vivo by chicken chorioallantoic membrane models.

139 Xenograft Panx1-KD cells grown within the chorioallantoic membrane of avian embryos developed tumo

140 cells from the two HT-1080 variants onto the chorioallantoic membrane of chick embryos and measured l

141 and BE(2)C cell lines, when engrafted on the chorioallantoic membrane of chick embryos, we observed a

142 ed on grafting of collagen onplants onto the chorioallantoic membrane of chick embryos.

143 ascular pattern formation was studied in the chorioallantoic membrane of chicken embryos (CAM assay).

144 y until an assay of ectodermal pocks of the chorioallantoic membrane of chicken embryos was introduc

145 ted in flow channel phantom data, and in the chorioallantoic membrane of chicken embryos with optical

146 of endothelial cells; (c) when placed on the chorioallantoic membrane of chicken embryos, these cells

147 s and promoted blood vessel formation in the chorioallantoic membrane of chicken embryos.

148 cell carcinoma xenograft model grown in the chorioallantoic membrane of chicken embryos.

149 ox, LoVo and SW-480 tumor transplants on the chorioallantoic membrane of embryonated hen eggs showed

150 x 3c also disrupted the blood vessels in the chorioallantoic membrane of fertilized chicken eggs.

151 d in two in vivo models of angiogenesis: the chorioallantoic membrane of the chick assay and the mous

152 They induce tumors in the chorioallantoic membrane of the chicken embryo and cause

153 products in collagen onplants grafted on the chorioallantoic membrane of the chicken embryo, we demon

154 ed expression of Hox D3 in vivo on the chick chorioallantoic membrane retained EC in this invasive st

155 ure of newborn condylar cartilage on a chick chorioallantoic membrane showed that after 5 d the cells

156 Tumor growth studies on the chick chorioallantoic membrane showed that C16Y reduces breast

157 neovascularization in an experimental quail chorioallantoic membrane system and Matrigel plug format

158 On the chorioallantoic membrane the 9E3 protein is chemotactic

159 constitutively expressed Hox B3 in the chick chorioallantoic membrane using avian retroviruses that r

160 ls of tumor cell intravasation in the distal chorioallantoic membrane using quantitative human-specif

161 he primary tumor (i.e., intravasate into the chorioallantoic membrane vasculature and metastasize to

162 cular permeability was assessed in the chick chorioallantoic membrane vasculature following minibeam

163 revented in vitro tube formation and in vivo chorioallantoic membrane vessel development.

164 g of human HT-1080 fibrosarcoma cells on the chorioallantoic membrane was used in conjunction with qu

165 PEX blocks MMP-2 activity on the chick chorioallantoic membrane where it disrupts angiogenesis

166 of zebrafish or local treatment of the chick chorioallantoic membrane with ScA resulted in dose-depen

167 etion reduced tumor development in a chicken chorioallantoic membrane xenograft model of human breast

168 y and migration assays) and in vivo (chicken chorioallantoic membrane) models and were found to exhib

169 mation, and suppresses angiogenesis in chick chorioallantoic membrane, after subcutaneous implantatio

170 It is angiogenically potent on chicken chorioallantoic membrane, but less so than angiogenin.

171 In chorioallantoic membrane, electron avalanche transfectio

172 itazone suppresses angiogenesis in the chick chorioallantoic membrane, in the avascular cornea, and i

173 rthermore, when grown in vivo in the chicken chorioallantoic membrane, primary tumors derived from Cx

174 After transplantation to the chick chorioallantoic membrane, the network reorganizes into a

175 antiangiogenic activity of HKa in the chick chorioallantoic membrane, was inhibited completely by an

176 ation and inhibits angiogenesis in the chick chorioallantoic membrane, whereas a fragment of TSP1 con

177 mediated Ras and c-Raf activity on the chick chorioallantoic membrane, whereas blockade of FAK or int

178 s on the primitive vascular bed of the chick chorioallantoic membrane, which has striking similaritie

179 wth factor-induced angiogenesis on the chick chorioallantoic membrane, with an IC50 of 10 microM.

180 ic rings and neoangiogenesis in chick embryo chorioallantoic membrane.

181 U human prostate cancer cells growing on the chorioallantoic membrane.

182 al growth factor-induced angiogenesis on the chorioallantoic membrane.

183 h factor-induced angiogenesis in the chicken chorioallantoic membrane.

184 hen applied to the rabbit cornea and chicken chorioallantoic membrane.

185 ctor-induced neovascularization of the chick chorioallantoic membrane.

186 sed avascular zones when placed on the chick chorioallantoic membrane.

187 of xenografted MKL-1 and WaGa tumors on the chorioallantoic membrane.

188 ort hairpin RNAs from cells that invaded the chorioallantoic membrane.

189 d genes and tested for invasion of the chick chorioallantoic membrane.

190 mbly and opposes angiogenesis in the chicken chorioallantoic membrane.

191 esis assays, the frog embryo and the chicken chorioallantoic membrane.

192 12 dose-dependently enhanced angiogenesis in chorioallantoic membranes (CAMs) and HUVECs.

193 astatic tumors within 2 wk of inoculation on chorioallantoic membranes (CAMs) of chick embryos.

194 r endothelial growth factor-stimulated chick chorioallantoic membranes and basic fibroblast growth fa

195 nists specifically inhibited angiogenesis in chorioallantoic membranes and in the retina and suppress

196 Breast cancer cells implanted on chick chorioallantoic membranes and treated with CoCl(2), to m

197 e containing hydrogel films applied to chick chorioallantoic membranes encourages neovascularization,

198 It also blocked the growth of tumors on the chorioallantoic membranes of 10-day chicken embryos.

199 in could inhibit the growth of tumors on the chorioallantoic membranes of chicken embryos and in syng

200 e xenografts in a novel system that employed chorioallantoic membranes of fertilized chicken eggs as

201 lginate-g-pyrrole hydrogel system on chicken chorioallantoic membranes resulted in the formation of b

202 scularized 3D tumors grown on chicken-embryo chorioallantoic membranes, and a syngeneic PC mouse mode

203 T-1080 fibrosarcoma cells grafted onto chick chorioallantoic membranes, which was similar to cisplati

204 ase 2 activation and angiogenesis on chicken chorioallantoic membranes.

205 ceptor) produced by trophoblast cells of the chorioallantoic placenta and acts on uterine natural kil

206 subpopulation of trophoblast cells exit the chorioallantoic placenta and enter the decidua.

207 ADA is enriched in trophoblast cells of the chorioallantoic placenta and is essential for embryonic

208 ultiple phenotypes including: defects of the chorioallantoic placenta and prenatal lethality; growth

209 Despite its importance in establishing the chorioallantoic placenta and umbilical circulation, the

210 The chorioallantoic placenta is a potential alternative targ

211 The chorioallantoic placenta is a shared derived feature of

212 trial vascular integrity, and disruptions in chorioallantoic placenta morphogenesis.

213 an enlargement of the junctional zone of the chorioallantoic placenta, a source of invasive trophobla

214 later in the labyrinthine trophoblast of the chorioallantoic placenta, where major defects are observ

215 ents to the embryo prior to development of a chorioallantoic placenta.

216 become the umbilical artery and vein of the chorioallantoic placenta.

217 coincident with the completion of the mature chorioallantoic placenta.

218 equently the labyrinthine trophoblast of the chorioallantoic placenta.

219 antois functions in the establishment of the chorioallantoic placenta.

220 her cells of the yolk sac placenta or in the chorioallantoic placenta.

221 ng expression of all 115 conserved eutherian chorioallantoic placentation genes in the uterus, an XY(

222 Although chorioallantoic placentation is initiated appropriately

223 ue in large part to failures in yolk sac and chorioallantoic placentation, die around embryonic day 1